By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Purdue Pharma L.P. (Connecticut) 

One Stamford Forum
Stamford  Connecticut  06901-3431  U.S.A.
Phone: 203-588-8000 Fax: 203-588-8850


Purdue Pharma L.P., headquartered in Stamford, CT, is a privately held pharmaceutical company founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care. Together with its independent associated companies, Purdue is dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The company has long been known for its pioneering research on persistent pain, a principal cause of human suffering.

Purdue also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue established Partners Against PainĀ® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

At its research facilities in Cranbury, New Jersey, Purdue scientists are discovering new compounds to treat pain and developing formulations and delivery systems to help improve patient safety.

Key Statistics

Ownership: Private

Web Site: Purdue Pharma L.P.
Employees: 1,650


Company News
Purdue Pharma L.P. Wins FDA Approval For Powerful Painkiller Hysingla 11/20/2014 12:56:24 PM
Zogenix, Inc. (ZGNX) And Purdue Pharma L.P. Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products 10/31/2014 7:32:49 AM
Purdue Pharma L.P. Release: New Research Highlights An Investigational Single-Entity Formulation Hydrocodone Bitartrate Extended-Release Tablet At PAINWeek 9/8/2014 8:06:10 AM
Purdue Pharma L.P. Receives FDA Approval For 7.5 Mcg/Hour Dosage Strength Of ButransĀ® (Buprenorphine) Transdermal System CIII 7/16/2014 9:21:44 AM
Purdue Pharma L.P. To Lay Off Staffers At Its Headquarters In Stamford 6/26/2014 6:25:46 AM
Purdue Pharma L.P. Reorganizes And Cuts One-Third Of R&D 6/18/2014 10:50:42 AM
California Counties Sue Drugmakers Actavis (ACT), Endo Pharmaceuticals (ENDP), Johnson & Johnson (JNJ), Purdue Pharma L.P. And Teva Pharmaceutical Industries Limited (TEVA) Over Painkiller Abuse 5/27/2014 8:32:33 AM
Purdue Pharma L.P. Names Saeed Motahari Senior Vice President and Chief Commercial Officer 5/22/2014 6:53:53 AM
Zogenix, Inc. (ZGNX) Falls As Rival Purdue Pharma L.P. Announces Positive Phase 3 Trial Of Abuse-Resistant Pill 3/12/2014 7:14:26 AM
Jobs Cut As Purdue Pharma L.P. Restructures 2/17/2014 7:43:36 AM